Razlike u biokemijskim reaktantima akutne faze i kvaliteti spavanja obzirom na tip krvožilnog pristupa u bolesnika liječenih hemodijalizom by Đorđe Pojatić et al.
Acta Clin Croat (Suppl. 1) 2021; 60:31-38 Original Scientific Paper
doi: 10.20471/acc.2021.60.s1.05
Acta Clin Croat, Vol. 60, (Suppl. 1) 2021  31
The differenCeS in biOChemiCAl reACTAnTS  
in The ACuTe PhASe/STAge And SleeP quAliTy 
COnSidering The TyPe Of vASCulAr ACCeSSS  
in PATienTS On hemOdiAlySiS
Đorđe Pojatić1,2,4, davorin Pezerović2,4, ivana Tolj1,5 and dunja degmečić1,3
1faculty of medicine Osijek, university Josipa Jurja Strossmayera, Osijek, Croatia;  
2faculty for dental medicine and health, university Josipa Jurja Strossmayera, Osijek, Croatia;  
3Psychiatric Clinic, Clinical hospital Centre Osijek, Osijek, Croatia;  
4general hospital vinkovci, vinkovci, Croatia;  
5 Clinic for internal diseases, dpt. of nephrology, Clinical hospital Centre Osijek, Osijek, Croatia
SummAry – in patients on hemodialysis (hd), there is a high prevalence of disturbed sleep 
quality caused by unknown causes. The study aimed to compare differences in the levels of biochemi-
cal reactants in the acute phase, creatinine, sociodemographic factors, alexithymia, and sleep quality in 
a group of hd patients considering the vascular approach, as well as to determine differences between 
hd patients with normal and low sleep quality and to determine predictive factors for sleep quality.
The research included 79 hd patients of both sexes, aged from 33 to 87, treated at uhC Osijek, 
general hospital vinkovci, and Outpatient clinic Županja. laboratory tests have been made on the 
hd, and clinical and sociodemographic information was collected.
The authors used the Croatian version of the Pittsburgh sleep quality questionnaire for Toronto 
alexithymia scale 26 and the epworth scale for daily sleepiness. hd patients who are dialysed through 
central venous catheter have significantly lower levels of albumins (p=0.02 mann-Whitney u test), 
creatinine (p=0.007 mann-Whitney u test), and they remain on dialysis for a shorter period of time 
compared to the patients with arteriovenous fistule (p=0.002 mann-Whitney u test). Patients who  
are longer on hd have a 1.395 times higher chance for lower sleep quality (Or = 1.395 95% Ci 1.02 
do 1.74). The only predictive factor for lower sleep quality in hd patients is the duration of hd 
 treatment.
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Introduction
in the Chronic Kidney disease (CKd) patients 
stage 5 (gfr under 15 ml/min), with oliguria or an-
uria, metabolic acidosis, and hyperkalemia, there is an 
indication for renal replacement Therapy (rrT) us-
ing dialysis or preparation for a kidney transplantation 
1. hemodialysis is a process that includes the diffusion 
of particles through a semipermeable dialysis mem-
brane using diffusion or diffusion/convection and ul-
trafiltration of excess body fluids 2. hemodialysis treat-
ment requires a lot of time with various somatic com-
plications, which can be frustrating for the patients 3.
hemodialysis access usually include arterio-venous 
fistula (Avf) or central venous catheter (CvC).
if it is possible, in hd patients, the preference is 
given to the Avf construction, considering that this 
approach of hemodialysis has fewer side-effects as 
muscle cramps and pruritus, and the possibility for in-
fections is reduced through CvC, which can be a po-
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tential source of blood infections (4). hd patients dial-
ysed through CvC catheter are usually in a worse so-
matic state than hd patients with Avf because it is 
often impossible to construct an adequate Avf due to 
generalised atherosclerosis and/or heart failure (5).
Alexithymia is a personality trait, a term, and a state 
that describes difficulties in identifying emotions expe-
rienced by one’s self or others and ways of thinking, 
which are led mainly by external factors instead of inter-
nal emotional states (6). Patients who are on hemodialy-
sis show significantly higher levels of alexithymia com-
pared to the general population, which can be explained 
in several ways (7). hd patients often have several co-
morbidities, they have dietary restrictions, and their 
treatment duration plays a role in their sense of well-
being. They also suffer from mental disorders and sleep 
disturbances, all of which are associated with higher 
levels of alexithymia in the general population (8,9).
Patients dialysed with a CvC usually have more 
comorbidities, a higher risk of systemic inflammation, 
and display more mental illness risk factors such as low 
body weight and old(er) age, which makes them simi-
lar to the alexithymic individuals in the general popu-
lation (10).
based on this, the hypothesis is that the hd pa-
tients with CvC will have poorer laboratory indicators 
of somatic health than the hd patients with Avf; 
that is, they will have higher levels of inflammation 
markers like C-reactive protein and lower levels of 
negative reactants in the acute phase such as haemo-
globin, albumin and creatinine.
because these patients frequently have muscle 
pains and cramps, night-time pruritus, and generally 
poorer quality of life, it is to be expected that they will 
also have a higher level of alexithymia, low sleep qual-
ity, and will suffer from daily sleepiness much more 
than the patients with Avf, which is an issue that has 
not been researched so far (4,10). Somatic issues such as 
locomotor pain, muscle cramps, and pruritus are, in 
fact, indicators of somatic health that are connected 
with high levels of alexithymia and sleep disturbances 
even in the general population (9).
in addition to the aim stated above, the purpose of 
this research is to determine the age differences, dura-
tion of renal replacement therapy and interdialytic 
yield of body mass between the two groups of patients 
(each group with a different circulatory approach).
independently of the earlier aim, another aim of 
this research is related to the quality of sleep of hd 
patients, determined by the PSq questionnaire: we 
aim to determine the differences in the stated clinical, 
biochemical, and sociodemographic variables, as well 
as in the levels of alexithymia, and to determine which 
factors are predictive of lower sleep quality in both 
groups of hd patients.
Patients and methods
research has been done as a cross-sectional study 
in the period from february 2019 to february 2020. 
79 hemodialysis patients (45 male and 34 female pa-
tients) at the department for nephrology in KbC 
Osijek, hemodialysis unit of health Center Županja, 
and nephrology department in general hospital 
vinkovci were included in the study.
hd patients were sampled by simple random se-
lection while strictly observing the study’s inclusion 
and exclusion criteria. hd patients are included in the 
study by strict observation of the exclusion and inclu-
sion criteria.
hd patients older than 18 years of age, who have 
been on the hemodialysis treatment or hemodiafiltra-
tion for at least three months, twice a week with every 
single hemodialysis duration not under three hours are 
included in the study. hd patients without heavier so-
matic or psychiatric diseases, like heart or liver failure, 
malignant disorder, major operations, or taking anti-
psychotics or antidepressants, are included in the study. 
excluded from the study were hd patients for whom 
we have subsequently determined some kind of so-
matic or psychiatric comorbidity or those who have 
not filled out the questionnaires used in the study.
Just before the hd procedure, the patients are re-
quired to give a laboratory sample for the analysis of 
the biochemical parameters like blood count, albu-
mins, creatinine, and from their medical files, we have 
collected data on the specificity of the hemodialysis 
process in every hd patient, such as the vascular ap-
proach and interdialytic mass yield. interdialysis mass 
yield is defined according to the formula: body mass of 
patients on dialyses - body mass at the end of the last 
hemodialysis / number of days between dialyses / dry 
body mass hd (11).
hd patients filled out the sociodemographic ques-
tionnaire with information about the vintage of the 
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hemodialysis treatment, age of the patients, and scale 
for the measurement of alexithymia: Toronto alexi-
thymia scale 26 (TAS 26), Pitsburg scale for sleep 
quality, epworth scale for daily sleepiness.
TAS 26 is a self-rated scale consisting of 26 particles 
grouped in 4 subscales that measure difficulties in iden-
tifying feelings, difficulties in describing one’s own feel-
ings, reduced ability of fantasy, and exterior oriented 
thinking. it is validated in the Croatian language (12). if 
an hd patient scores 62 points and less on the scale, 
they are not alexithymic; score values from 63 to 73 rep-
resent moderate levels of alexithymia, while scores over 
74 represent high levels of alexithymia.
To determine sleep quality, hd patients filled out 
the Pitsburg scale (Pitsburg Sleep quality index 
(PSq)) with 19 particles, grouped in 7 components for 
the elaboration of subjective sleep quality, time to fall 
asleep, duration of sleep, effective sleep, use of medica-
tions, daily functioning and disturbances during the 
sleep in the last month (13). Patients with PSq score 5 
and higher are hd patients with low quality of sleep 
or ”poor sleepers”. To measure daily sleepiness, the au-
thors used the epworth scale for daily sleepiness 
(eeS), a self-rating questionnaire with 8 offered par-
ticles. every one of those measuring the respondents’ 
daily sleepiness in described hypothetical situations. it 
is validated for usage in the Croatian language (14).
The authors have obtained approval of the ethics 
Committees of uhC Osijek, general hospital 
vinkovci, and Outpatient clinic Županja for conduct-
ing the research.
Statistical methods
The normal distribution of numerical data in the 
study has been tested with the Shapiro-Wilk test. nu-
merical data are presented with the arithmetic mean 
and standard deviation in the distribution, which fol-
low a normal distribution, and in other cases with me-
dian and borders of the interquartile span. The differ-
ences in the numerical data between the CvC and 
Avf group of hd patients in the case of a normal 
distribution are tested with Student’s t-test, and in the 
case of nonparametric distribution with man-Whit-
ney u test.
for the assessment of differences in biochemical, 
clinical, and sociodemographic variables relative to the 
sleep quality, hd patients are divided according to the 
score on the PSq scale into groups of poor and good 
sleepers, independently of the type of vascular ap-
proach used in the hd treatment. The differences in 
biochemical, clinical, and sociodemographic variables 
among hd patients with regular and low sleep quality 
are tested in the case of a normal distribution with 
Student’s t-test and in the case of nonparametric dis-
tribution with man- Whitney u test, whereas the dif-
ferences between categorical variables have been tested 
with a χ2 test.
logistic regression is used for the analysis of 
many factors on the probability of sleep disorders in 
the sample of hd patients. SPSS (16.0, SPSS inc., 
Chicago, il, SAd) has been used for statistical ana-
lysis.
Table 1. Distribution of respondents characteristics according to CVC and AVF group
median (25%-75%) P*CvC patients Avf patients
age (years) 67 (62 - 72) 66 (52 - 75) 0.31
vintage of hd (years) 1.1 (0.3 – 2.6) 3 (1.3 - 5.1) 0.002
CrP 5.3 (2.1 - 16.7) 3.7 (1.8 - 8.3) 0.10
Albumin 36.4 (32.9 - 38.1) 37.7 (35.7 - 39.5) 0.02
hemoglobin 105.5 (94.8 - 111.8) 108 (103 - 116) 0.09
interdialysis yield 1 0.8600 (0.01-1.46) 0.8600 (0.00-1.86) 0.733
interdialysis yield 2 0.9250 (0.00-2.80) 0.900 (0.00-2.35) 0.558
interdialysis yield 3 0.9500 (0.00-2.00) 0.9500 (0.00- 2.25) 0.650
Sleep quality (PSq) 7 (4-11) 5.5 (4-9) 0.093
daily slepiness (eSS) 6 (3.25-11) 7 (4-11.75) 0.650
*man Whitney u test
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Table 2. Distribution of the respondents’ characteristics 
according to CVC and AVF group
Arithmetic mean  
(st. deviation) P*
CvC group Avf group
creatinin before 
hemodialyses 654 (212) 800 (237)
0.005
alexithymia 67.22 (21.23) 66.87 (15.93) 0.933
*Student-‘s t-test
Table 3. Distribution of respondents according to results on PSQ questionnaire
median (25%-75%) P*good sleep Poor sleep
age (years) 61.5 (52.8 - 68.5) 69 (63.5 - 75) 0.10
lenght hd 1.7 (0.7 - 3) 2.5 (0.8 - 6.5) 0.24
CrP 5.4 (1.3 - 10.2) 4.67 (2.3 - 10.6) 0.52
Albumins 37.9 (34.7 - 39.8) 37.05 (35.2 - 38.4) 0.31
hemoglobin 108 (101.8 - 114.3) 107 (102.3 - 112) 0.63
interdialysis weight 1 0.86 (0.3 - 1.1) 0.8 (0.6 - 1.2) 0.82
interdialysis weight 2 0.95 (0 - 1.3) 0.9 (0.4 - 1.6) 0.38
interdialysis weight 3 1.05 (0.4 - 1.3) 0.95 (0.6 - 1.5) 0.64
daily sleepiness (eSS) 6 (3-10) 6.5 (3.25-11) 0.766
*man Whitney u test
Results
The study included 79 hd patients, 37 of which 
were in the group of CvC hd patients, and 42 in the 
Avf group of hd patients.
Avf hd patients have been significantly longer 
dialysed than the hd patients in the CvC group 
(p=0.002 man Whitney u test). hd patients with ar-
teriovenous fistule had significantly higher albumin 
levels than the hd patients in the CvC group (p=0.02 
man-Whitney u test).
in the group of hd patients with Avf, there is a 
negative correlation between levels of CrP and albu-
mins (Spearman correlation, ρ=-0.594 p <0.001), while 
in the CvC group, there is no such connection (Spear-
man correlation, ρ= -0.12 p=0.950). There is no sig-
nificant difference between patients with CvC and 
Avf in the levels of daily sleepiness (p=0.650 man-
Whitney u test) and the quality of sleep (p=0.093 
man-Whitney u test).
hd patients in the CvC group have a significant-
ly lower creatinine level before hemodialysis than the 
hd patients in the Avf group (p=0.005 Student’s t-
test). Still, there is no difference in alexithymia levels 
between the two groups (p=0.933 Student’s t-test).
in further analysis, hd patients from both groups 
are divided based on their score on the Pitsburg sleep 
quality scale into hd patients with or without distur-
bances in sleep quality for the purpose of assessing the 
differences in the observed variables. TThere are 32 
hd patients with sleep disturbances and 47 hd pa-
tients without sleep disturbances in the sample.
There were no statistical differences between ob-
served groups of respondents.
hd patients in groups of good and bad sleepers are 
not different compared to the levels of alexithymia 
(p=0,546 Student’s t-test).
CvC and Avf group of hd patients exhibit no 
difference based on the quality of sleep (p=0.15 χ2 test).
logistic regression is used to rate the contribution 
of many factors on the probability of poor sleep (de-
pendable variable). for the independent variables, age, 
sex, vintage of hd, CrP, albumins, hemoglobin, and 
interdialytic weight, and the type of vascular approach 
(CvC or Avf) were considered. for the conduction of 
the prediction model of poor sleep quality, multivari-
ant logistic regression has been used.
for selecting the predictors, Stepwise logistic re-
gression has been used, the criterion of statistical sig-
nificance higher than 0.10 has been used, and research 
criterion 0.2 was the chosen border level. Only one 
predictor has a statistically significant contribution to 
the model, and that was the vintage of hemodialysis 
(hosmer – lemeshow test, P = 0.56). The model is in 
total statistically significant (χ2 = 9.18, P = 0.002), and 
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in total explains between i 18% (based on Cox & Snell) 
and 24.7% (based on negelkerke) variance of bad 
sleep, and correctly classifies i 53,3% cases. respon-
dents who have been on hd for a longer period of 
time have a 1.34 times higher chance of poor sleeping 
(Or = 1,34 95%Ci 1,02 do 1,74).
Discussion
it is well-known that hd patients with CvC have 
a higher incidence of mortality, more comorbidities, 
and a higher risk of infections compared to hd pa-
tients with Avf 15.
Although research suggests that hd patients with 
CvC are on average older than patients with Avf, this 
is not the case in this study (16). between the two groups 
of hd patients, the only significant difference is the 
duration of the treatment with hemodialysis in the 
case of the patients with constructed Avf. in accor-
dance with the study’s hypothesis, the CvC group of 
hd patients has slightly higher levels of C-reactive 
protein compared to the Avf group of hd patients. 
The difference is on the border of statistical signifi-
cance, and this hypothesis should be tested on a more 
significant sample of patients. however, this result still 
shows the vulnerability of the CvC group of hd pa-
Table 4. Distribution of respondents according to CVC 
and AVF group
Arithmetic mean  
(standard deviation) P*
good sleep Poor sleep




763 (268) 750 (203)
0.815
*Student’s t-test
Table 5. The Respondents’ Results based on the PSQ Questionnaire 
number of subjects (patients) (%) P*Sleeping Well Sleeping Poorly Total
CvC group 8 (28.6) 23 (45.1) 31 (39.2) 0.15Avf group 20 (71.4) 28 (54.9) 48 (60.8)
Total 28 (100) 51 (100) 79 (100)
*χ2 test
tients, considering that this vascular approach is con-
nected with a higher level of systemic inflammation. A 
significantly lower level of albumins and the tendency 
to lower hemoglobin levels in this group could be ex-
plained by the fact that these proteins are negative re-
actants of the acute phase, allowing the possibility of 
connecting their levels with systemic inflammation to 
which these hd patients are inclined.
hd patients with CvC score somewhat higher in 
the Sleep quality questionnaire (Table 1), which is in 
line with current research, as this group of patients is 
more prone to muscle cramps and uremic pruritus that 
objectively prevent falling asleep and sleeping (4). The 
differences between the two groups, however, are not 
statistically significant, so the research should be con-
ducted with more subjects (more hd patients) to en-
sure that there is no statistical error type two, that is, 
the failure to detect existing differences due to a small 
sample of respondents (17).
The connection between sleep quality and the type 
of vascular approach in hd patients has only been 
tested in a small number of studies. Although the re-
sults are contradictory, more studies have shown that 
patients with CvC have poorer (lower) sleep quality 
(10). it is possible that the poor sleep quality in CvC 
hd patients is connected to the levels of haemoglo-
bin, albumin and somewhat higher levels of the sys-
temic inflammatory markers such as CrP, which are 
on the margin of statistical significance in our results, 
and that they represent a possible pathophysiological 
mechanism of influence of somatic health on the qual-
ity of sleep. This opens up the possibilities for further 
research on the subject.
A novel piece of data, so far undescribed in litera-
ture, is the realization of the equal levels of hd pa-
tients’ daily sleepiness, regardless of the vascular ap-
proach. daily sleepiness is a factor that is connected to 
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the high incidence of other morbidities, it lowers the 
quality of life of people in the general population, 
making their daily functioning more complicated, and 
in the population of hd patients, it is even more ex-
pressed than in the general population (3). The results of 
our study point to the fact that the choice of the vascu-
lar approach in hd patients is not related to the levels 
of their daily sleepiness.
Although, in studies done so far on the population 
of hd patients, alexithymia is connected with the vin-
tage of hemodialysis, anemia and a higher number of 
comorbidities, the authors haven’t found a difference 
in the level of alexithymia in hd patients based on the 
type of vascular approach (6, 17).
Avf group of hd patients has been dialysed sig-
nificantly longer and, based on current research, higher 
levels of alexithymia should be expected considering 
that the duration of dietary restrictions and everyday 
frustration is longer (18).
Significantly higher levels of albumins and the ten-
dency towards higher levels of hemoglobin and lower 
levels of CrP in the Avf group of hd patients point 
to a better somatic state in this group, which points out 
the need for the evaluation of the number and serious-
ness of their comorbidities as well as assessment of the 
levels of alexithymia between the two groups consider-
ing the fact that this represents a limitation of our 
study (19).
if we categorize hd patients into groups with 
good and poor sleep quality based on their PSq ques-
tionnaire score, regardless of the vascular approach 
used in their treatment, it is clear that there is no sta-
tistical difference in age or duration of dialysis treat-
ment, biochemical variables, and interdialysis yield, 
which is partially in line with the current research on 
the quality of sleep in hd patients (20,21).
hd patients with CvC have a higher score on the 
sleep quality scale, which is in accordance with previ-
ous results, considering the fact that this group of pa-
tients has a tendency toward muscular cramps and 
uremic pruritus, which represent objective disturbanc-
es for falling asleep and sleeping (4). The differences 
between the two groups are not statistically significant; 
therefore, research should be done on a larger sample 
of hd patients to avoid the possible statistical mistake 
type two, that is, the existence of differences that are 
not detectable due to a small sample (20).
if hd patients are divided according to the PSq 
scale result, in groups with normal and with poor sleep 
quality, independently of the type of vascular approach, 
there are no statistical differences in age, vintage of di-
alysis treatment, biochemical variables, and interdialy-
sis mass yield. The absence of a connection between 
sleep quality and biochemical variables like CrP, albu-
mins, hemoglobin, and creatinine is partly in accor-
dance with the previous conclusions about sleep qual-
ity in a population of hd patients (21,22). Consistent 
results about the connection between lower sleep qual-
ity and biochemical parameters exist only if we take 
into consideration an overall scale, like malnutrition-
inflammatory score (miS), which assesses the general 
condition of hd patients in relation to inflammatory 
variables and nutrient intake (23). A similar type of re-
search should be done in the future when rating the 
inflammatory-nutritive status of hd patients.
even though the studies done so far show a con-
nection between lower sleep quality and volume status 
in hd patients, we could not confirm the connection 
described with high interdialyses fluid delivery in hd 
patients (24). The reason for this is probably in the fact 
that interdialyses fluid delivery on hemodialysis doesn’t 
necessarily represent the volume status of hd pa-
tients, which should be measured with sensitive meth-
ods like bioimpedance (25).
in studies done so far in hd patients with heavy 
hyperparathyroidism, alexithymia is a factor that is di-
rectly connected with lower sleep quality and normali-
sation of sleep quality after paraidectomy. it is a pre-
dictive factor for the reduction of the levels in alexi-
thymia (26).
in studies performed in the general population, 
alexithymia and lower sleep quality are connected 
through depression because the connection of alexi-
thymia and sleep quality disappears when the effects of 
depression are included in the analyses (27).
There have been no similar studies so far, so our 
results have scientific significance as the first analysis 
of the connection between sleep quality and alexi-
thymia on hd patients’ population without serious 
somatic and mental disorders.
Sleep quality is a concept dependant on age-sex 
characteristics, as women develop sleep disorders more 
often than men, and that aging increases the appear-
ance of disturbances of sleep quality (28).
in the statistical model in which we have included 
age, sex, biochemical variables, and interdialytic mass 
yield, the only factor that predicts lower sleep quality is 
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the vintage of the hemodialysis treatment, and every 
additional year of the hemodialysis treatment contrib-
utes a 1.34 higher possibility that an hd patient will 
develop disturbance in sleep quality. based on the re-
sults, it is possible to determine that hemodialysis 
treatment, regardless of the biochemical and sociode-
mographic variables and the type of vascular approach, 
sex, age, and biochemical variables, contributes to the 
lower sleep quality. dietary measures, a tendency to-
ward developing a depressive disorder, everyday frus-
trations connected with time consumption, lower so-
cioeconomic status, and somatic difficulties are factors 
that can contribute to the described deterioration (23, 29).
Additional studies are needed on larger samples in 
order to determine if the existence of long-term com-
plications of hemodialysis, such as muscle cramps and 
hypotension or more comorbidities in older age of hd 
patients, is crucial for the development of poor sleep 
quality in hd patients. The necessity for additional 
studies arises from the fact that sleep disturbances are 
one of the factors which significantly contribute to 
lower quality of life and morbidity of hd patients (30).
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Sažetak
rAZliKe u biOKemiJSKOm reAKTAnTimA AKuTne fAZe i KvAliTeTi SPAvAnJA  
ObZirOm nA TiP KrvOŽilnOg PriSTuPA u bOleSniKA liJeČenih hemOdiJAliZOm
Đorđe Pojatić, Davorin Pezerović, Ivana Tolj i Dunja Degmečić
u bolesnika liječenih hemodijalizom (hd) postoji visoka prevalencija poremećaja kvalitete spavanja s nedovoljno utvr-
đenim uzrocima. Cilj istraživanja je usporediti razlike u razinama pojedinih biokemijskih, sociodemografskih čimbenika, 
aleksitimije i kvalitete spavanja u skupinama hd bolesnika s obzirom na tip vaskularnog pristupa, odrediti i razlike između 
hd bolesnika sa urednom i sniženom kvalitetom spavanja i utvrditi prediktivne faktore snižene kvalitete sna.
u istraživanju je sudjelovalo 79 ispitanika oba spola liječenih hemodijalizom, dobnog raspona između 33 do 87 godina iz 
KbC Osijek, OŽb vinkovci i dZ Županja. hd bolesnicima su uzeti uzorci krvi za laboratorijsku analizu te su zabilježeni 
klinički i sociodemografski podaci.
bolesnici su anketirani pomoću hrvatske inačice Pitsburškog upitnika za mjerenje kvalitete spavanja, Toronto aleksiti mija 
skale 26 i epworthove ljestvice dnevne pospanosti. hd bolesnici koji se dijaliziraju preko centralnog venskog katetera imaju 
značajno niže vrijednosti albumina (p=0,02 mann-Whitney u test), kreatinina (p=0,007 mann-Whitney u test) i kraće se 
dijaliziraju u odnosu na bolesnike sa arteriovenskom fistulom (p=0,002 mann-Whitney u test). ispitanici koji su dulje vrije-
me na hd imaju 1,395 puta veću šansu za sniženu kvalitetu spavanja (Or = 1,395 95%Ci 1,02 do 1,74). Jedini prediktivni 
faktor snižene kvalitete spavanja u hd bolesnika je trajanje liječenja hemodijalizom.
Ključne riječi: aleksitimija, hemodijaliza, kvaliteta spavanja, krvožilni pristup
